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Objectives: To estimate the prevalence and losses in quality-adjusted life years 
(QALYs) associated with 20 child health conditions. MethOds: Using the 2009-2010 
National Survey of Children with Special Health Care Needs, preference weights were 
applied to 14 functional difficulties to summarize the quality of life burden of 20 
health conditions. Furthermore, a scatterplot shows the association between condi-
tion prevalence and burden. Results: Among the 14 functional difficulties, “a little 
trouble with breathing” had the highest prevalence (37.1%), but amounted to a loss 
of just 0.16 QALYs from the perspective of US adults. Though less prevalent, “a lot 
of behavioral problems” and “chronic pain” were associated with the greatest losses 
(1.86 and 3.43 QALYs). Among the 20 conditions, allergies and asthma were the most 
prevalent but were associated with the least burden. Muscular dystrophy and cerebral 
palsy were among the least prevalent and most burdensome. cOnclusiOns: In child 
health, condition prevalence is negatively associated with quality of life burden from 
the perspective of US adults. Both should be considered carefully when evaluating 
the appropriate role for public health prevention and interventions.
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Objectives: Maternal depression is hypothesized as a risk factor for compromised 
health-related quality of life (HQOL) during pregnancy. The objective of our study 
was to compare HQOL for pregnant women with or without depression and provide 
evidence for early detection of depression during pregnancy in China. MethOds: 
Women at the third trimester of pregnancy were consecutively recruited from ante-
natal clinics of West China Second Hospital between October 2013 and February 2014 
in Chengdu, China. They were surveyed using a questionnaire comprised of basic 
information of pregnant women, the Chinese version of the Edinburgh Postnatal 
Depression Scale (EPDS), and the Generic Medical Outcomes Study Short Form-36 
(SF-36). Results: A total of 2242 pregnant women aged 30.0 ± 4.0 years responded 
to our survey. Compared with women with depression during pregnancy (EPDS 
score≥ 13), those without antepartum depression (EPDS score<13) had higher HQOL 
scores. SF-36 dimension scores (mean ± SD) for the two groups were 59.69±18.72 vs 
63.24±16.53 for physical function (PF); 43.10±24.66 vs 52.05±24.90 for role-physical (RP); 
59.90±19.65 vs 70.21±17.61 for body pain (BP); 60.98±17.92 vs 74.23±15.32 for general 
health (GH); 50.84±15.40 vs 62.19±14.50 for vitality (VT); 65.09±18.66 vs 76.82±16.99 for 
social function (SF); 55.49 ± 26.55 vs 75.37±25.80 for role-emotional (RE); and 62.20 ± 
13.33 vs 80.59±10.62 for mental health (MH) (P < 0.01 for comparisons in each dimen-
sion). Multiple linear regression analysis showed that EPDS scores were statistically 
associated with SF-36 scores (beta= -3.81 for PF; -9.07 for RP; -10.52 for BP; -11.36 for 
GH; -10.17 for VT; -11.99 for SF; -18.37 for RE; and -17.50 for MH. P＜0.01 for all compari-
sons). cOnclusiOns: Pregnant women with depression show poorer HQOL during 
pregnancy than those without depression. It indicates a necessity for routine screen-
ing of maternal depression to relieve its negative impact on pregnant women’s life.
PIH39
unDerStanDIng aPParent HealtH OutCOMe DISParItIeS BetWeen 
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Objectives: This study aims to understand ethnic group disparities in health out-
comes by examining health-related quality of life (HRQoL), work productivity loss, 
and resource use. MethOds: The data came from the 2013 US National Health and 
Wellness Survey, a representative, cross-sectional general health survey (N= 75,000). 
Respondents were categorized into ethnic groups based on self-reported race 
and Hispanic origin questions: White (n= 57,916), Black (n= 7,855), Hispanic/Latino 
(n= 6,192), Asian (n= 3,792), Other/Multi-ethnic (n= 2,534). Differences were exam-
ined for HRQoL (SF-36v2: mental and physical component summary (MCS, PCS) 
and SF-6D (health utility) scores), productivity loss (Work Productivity and Activity 
Impairment questionnaire), and resource use in the past 6 months. Initial analyses 
used one-way ANOVAs and multivariable generalized linear models were used to 
control for demographic and health characteristics (e.g., income) to examine the 
unique effect associated with ethnicity. Results: Preliminary comparisons revealed 
White respondents had the highest MCS scores (Mean= 49.41) and health utility scores 
(M= 0.74) whereas Hispanic/Latinos and Other had the lowest MCS (M= 46.13, M= 46.74, 
respectively) and health utility (M= 0.71, M= 0.70) scores (all ps< .05). Asian respondents 
had the highest PCS scores (M= 52.20) with Other having the lowest (M= 49.19; p< .05). 
Overall, White respondents had less work productivity loss (M= 14.17%) and activ-
ity impairment (M= 22.22%) than Hispanic/Latino (work productivity loss M= 22.30% 
and activity impairment M= 24.41%) or Other (work productivity loss M= 19.06% and 
activity impairment M= 26.20%; all ps< .05). Relative to Hispanics, White respondents 
reported less ER visits (M= 0.19 vs. 0.34) and hospitalizations (M= 0.11 vs. 0.23; all 
ps< .05). Adjusted models lessened many of these differences, often likening White 
respondents to those of ethnic minority groups. cOnclusiOns: Initial analyses 
showed White respondents had higher HRQoL, less work and activity impairment, 
and lower resource use. However, after controlling for confounders, many of those 
differences were minimized indicating that factors other than ethnicity may more 
strongly influence health outcomes such as income.
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Objectives: Many economic analyses fail to incorporate evidence on child health-
related quality of life (HRQoL) due to a paucity of quality-adjusted life year (QALY) 
estimates. This health valuation study is the first to summarize the EQ-5D-Y on a 
QALY scale. MethOds: Drawn from a nationally representative panel, 5207 adult 
respondents were asked to choose between 2 losses in child HRQoL. Results: Based 
on their choices, a 1-year increase in child pain/discomfort from “some” to “a lot” 
equals a loss of 4 QALYs (CI 95% 3.8-4.4). Likewise, a 1-year increase in child anxiety/
depression from “a bit” to “very worried, sad or unhappy” equals a loss of 2 QALYs (CI 
95% 1.9-2.2). cOnclusiOns: These findings enable the integration of child-reported 
outcomes with adult preferences to inform economic analysis. Results inform both 
clinical practice and resource allocation decisions by enhancing understanding of 
difficult tradeoffs in child-reported outcomes.
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Objectives: By summarizing the value adults place on child health and functional 
status, this study provides a new quantitative tool that enhances our understanding 
of the benefits of new health technologies and illustrates the potential contributions 
of existing datasets for comparative effectiveness research in pediatrics. MethOds: 
Respondents, ages 18 and older, were recruited from a nationally representative 
panel between August 2012 and February 2013 and completed an online sur-
vey with a series of paired comparisons. Specifically, they chose between child 
health and functional status outcomes; these were described using the National 
Survey of Children with Special Health Care Needs, a 14-item descriptive system 
of child health outcomes, ages 0 to 17 years. Using respondent choices regarding 
an unnamed 7- or 10-year-old child, generalized linear model analyses estimated 
the value of child health and functional status on a quality-adjusted life year 
scale. Results: Across the domains of health and functional status, repeated or 
chronic physical pain, feeling anxious or depressed, and behavioral problems (such 
as acting out, fighting, bullying, or arguing) were most valuable, as indicated by adult 
respondents’ preference of other health problems to avoid outcomes along these 
domains. cOnclusiOns: These findings may inform comparative effectiveness 
research, health technology assessments, clinical practice guidelines, and public 
resource allocation decisions by enhancing understanding of the value adults place 
on health and functional status of children. Improved measurement of public priori-
ties can promote national child health by drawing attention to what adults value 
most and complementing conventional measures of public health surveillance.
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SavIng SOlutIOnS fOr uS PayerS
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Objectives: Gilead implemented a tiered global pricing strategy for SOVALDI where 
the price reflects a county’s ability to pay; a 12-week treatment course in the US 
costs $84,000 versus $840 in India, Egypt and Brazil. SOVALDI has generated some 
strong payer outcry as its price combined with the large patient population results 
in a substantial budget impact. This research aimed to evaluate how it could be 
money-saving for US insurers to reimburse patients for luxury holidays to Egypt 
where SOVALDI is available at a 99% discount. MethOds: On the 26th November 
2014, prices were sourced for the Fairmont Cairo 5-star hotel alongside first-class 
flights on Emirates airline for trips at the following weekend (Friday 28th to Sunday 
30th November) reflecting the potential need for prompt commencement of treat-
ment following diagnosis. Results: The most expensive suite at the Fairmont Cairo 
was the 233m2 “Diplomatic Suite King,” overlooking the Nile at $10,000 a night for 
2 people. First-class flights for 2 persons leaving on the 28th November and return-
ing on the 30th would cost $42,754. Therefore, US insurers could afford to send 
hepatitis C patients along with a friend/partner on a luxury weekend break to the 
most expensive suite in a 5-star hotel in Cairo to collect their SOVALDI prescription 
for a total of $63,594. This means that insurers could give the patient an additional 
$10,000 in spending money and still make cost-savings exceeding $10,000, as com-
pared to having SOVALDI dispensed in the US. cOnclusiOns: The availability of 
high-cost therapeutics in other countries at a fraction of the price that it costs in the 
US, offers opportunities for US payers to save costs whilst simultaneously offering 
quality-of-life improving vacations for patients. Is it feasible to offer patients such 
options? If so, could increasing international price arbitrage for pharmaceuticals 
open a new market?
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Objectives: Training courses are provided for human capital services that strive 
to make proper talent management a competitive advantage for producers in the 
US livestock market. This analysis measures the effectiveness of the training pro-
gram including ROI, identifies the demographics of the most successful learners 
and necessary program adjustments. MethOds: Utilizing a survey data collec-
tion instrument and analytics software application that includes program specific 
benchmarks, course participants were invited to complete a Follow Up survey > 2 
mos. post completion. Survey data from November 2012-December 2014 includ-
ing 124 Follow up surveys and 19 Manager surveys were analyzed. For Likert-type 
questions (1 – 5 response scale) a percent favorable, also known as a top two box, 
was used to display response data. For percentage based questions (0%-100% 
response scale in 10% increments), a simple average calculation was used to dis-
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play response data. Analysis by question, category and demographic descriptor was 
performed. Results: 90% of learners were able to apply the content of the training 
within 4 weeks. Learners reported a notable increase in improving animal health 
and production as a result of the training. Most learners (> 90%) view the program 
as a worthwhile investment in their career. Significantly less managers feel the 
same way (< 45%). A ROI calculation result for total percent job improvement due to 
training is 1.7 times the top 25% benchmark. Surprisingly, those with greater than 
10 years tenure find the program to be just as worthwhile or more compared to the 
other tenure groups and the group with the largest number of employees also saw 
the greatest Job Impact from the training. cOnclusiOns: The training provides 
much needed resources for the industry since most learners found it a worthwhile 
investment and the ROI calculation is high. This analysis allows for data driven 
decisions to be made for program adjustment and learner selection.
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Objectives: In a previous study we found a steep increase in the use of the term 
“patient-centered” in the published literature from < 10 articles in the 1960s to > 3000 
in the 2010s. We also noted an increase in the proportion of articles in each decade 
reporting original research (17 vs 90%). The objective of this study was to further 
examine the subset of articles reporting original research. MethOds: We searched 
EMBASE for articles written in English between 1950-2013 with ‘patient-centered’ in 
the title or abstract. We selected a random sample of 10 articles within each decade 
and captured data from the title and abstract on the focus of the article (healthcare, 
research, or teaching). We selected those focused on research and extracted additional 
data on the study design, data collection methods, number of cases, comparator 
group, and statistics used. We examined trends in these variables over time using 
tabular and graphical methods. Results: Our search identified 5051 publications, 
of which 2222 reported original research, from 1966-2013. Articles in earlier decades 
tended to report qualitative research (> 55%), whereas articles published since 2010 
used more sophisticated study designs (> 75%). The majority of studies in all decades 
employed descriptive statistics; however multivariate methods were used in 25% 
of studies in the 2010s. The use of a comparator group (16 vs 50%) and the average 
number of subjects (38 vs 687) also increased steadily over time. cOnclusiOns: In 
addition to the increase in original research publications with “patient-centered” 
in the title or abstract over the last 50 years, we observed an increase in scientific 
and methodological rigor among these original research articles. These findings are 
consistent with the rise in personalized-medicine in the healthcare industry today, 
as well as the upsurge in the use of patient-reported outcome data that characterizes 
clinical research today.
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Objectives: Patients with barriers such as normal anxiety around illness, low asser-
tiveness, or cognitive issues may have trouble communicating with their healthcare 
providers (HCP). HCPs are under increasing pressure to see more patients daily. Can 
a web-based training and worksheet help patients have improved outcomes, even in 
the face of these challenges? MethOds: US and European patients were trained to 
produce an electronic, printable worksheet that contained the following: a detailed 
description of their primary complaint, including location, duration, and intensity 
according to Likert scale, correlation to activity, quality, and history. The worksheet 
also included a functional impact statement around daily activities of living and 
social activities, a therapy preferences statements and a statement of symptom 
management goals. Results: Of 25 patients, 14 responded to an outcomes survey: 
10/14 (71%) of the respondents were female, with a range of 30-72 years of age 6/14 
(42.9%) consulted 5 or more HCPs and 9/14 (64.3%) had 5 or more healthcare visits 
for their healthcare issue prior to completing the worksheet 9/14 (64.3%) indicated 
they had some miscommunication with their HCP regarding medication A major-
ity of patients had received costly blood tests (81.8%), X-rays (72.7%), and MRI/CATS 
scans (63.6%) for their healthcare issue Most patients (78.6%) used the worksheet to 
have a discussion around a new treatment option they hadn’t previously discussed, 
and almost half 6/14 (42.9%) were able to get a diagnosis for a healthcare issue not 
previously diagnosed using the worksheet; Many [9/14 (64.3%)] said the worksheet 
helped reduce office-visit related anxiety and helped them discuss symptom man-
agement [8/14 (57.2%)]. cOnclusiOns: This simple web-based tool was useful in 
facilitating communication between patients and their HCPs, which led to diagno-
sis, receiving new treatments, and better symptom management, even in patients 
with long-standing healthcare issues, multiple visits, extensive testing, and multiple 
healthcare providers.
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Objectives: Identify the current and future relevance of Patient Reported 
Outcomes (PROs) among U.S. payers making patient access decisions for pharma-
ceuticals MethOds: Double blind, semi-structured telephone interviews with 12 
U.S. payers, including: National and regional commercial payers; Accountable Care 
Organizations; Pharmacy Benefit Managers; Self-insured employers; Actuaries; 
Veterans Affairs; and Department of Defense. Interviews included open-ended 
questioning and structured rating scales where 10= highest and 1= lowest possible 
score per concept. Results: Payers perceive PROs as the, “Consequences of the 
disease and drug as assessed by the patient...” Average rating scale responses were: 
How relevant are PROs? today? = 3.7 in 5 years? = 6.4 Would you like to see more PRO 
evidence? today? = 6.1 in 5 years? = 6.6 Should pharmaceutical companies invest 
more in PROs? today? = 5.6 in 5 years? = 6.3 The sum of the 6 scales (min= 6, max 
= 60) ranged from 12 to 58, highlighting diversity across payers. PRO relevance was 
associated with the duration of enrollment and thus total amount of risk. DoD and 
ACOs reported the highest relevance, National Commercial Health plans the lowest. 
Education was consistently identified as a need to aid interpretation of PRO data to 
support patient access decisions. cOnclusiOns: Payers’ reliance on PRO data will 
increase in the next five years, especially in symptomatic conditions without objec-
tive measures of success. PRO evidence is valued as a unique predictor of clinical 
and economic outcomes and as a key element of performance and quality ratings. 
Respondents showed interest in pharmaceutical companies’ increasing use of PROs 
in clinical trials, creation of real world evidence and supporting PRO education.
PIH47
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Objectives: The objective of this research is to evaluate whether the 2009 FDA PRO 
Guidance leads to development of similar measures when followed by different 
researchers in the same disease. Psoriasis was selected as a case study, because 
two companies recently published patient-reported outcome measures to assess 
the severity of psoriasis-related symptoms: the Psoriasis Symptom Inventory (PSI) 
and the Psoriasis Symptom Diary (PSD). MethOds: Full-length publications related 
to the development of the PSI and PSD were reviewed. The following information 
regarding the development process and key aspects pertinent to the PRO Guidance 
were extracted and compared: patient population, development steps (literature 
review, involvement of patients during item development), psychometric proper-
ties, content of final measure, recall period, response options, and scoring. The 
authors conducted a qualitative evaluation of the differences between the meas-
ures. Results: Five publications regarding the development of the measures were 
identified (PSI, n = 3; PSD, n = 2). Both measures focus on symptoms of moderate 
to severe psoriasis. Both measures were based on literature reviews, patient input, 
and expert opinion and had similar psychometric properties. Both measures have 
a 24-hour recall period. However, the measures consist of different numbers of 
disease-specific symptoms (PSI = 8; PSD = 6). The PSI consists of 8 items, all of which 
measure symptom severity. The PSD consists of 16 items (bother of symptoms = 8, 
severity of symptoms = 6, skin color = 1, hiding skin = 1). Additionally, the measures 
assess symptoms differently. The PSI uses a 5-point Likert scale, while the PSD uses 
an 11-point numeric rating scale; both measures equate higher scores with greater 
severity. cOnclusiOns: This example demonstrates that when different experts 
develop patient-reported outcome measures to assess identical concepts and to 
align with the FDA PRO Guidance, the result is similar but not identical.
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Objectives: There is a dearth of evidence on factors influencing prescription plan 
switching versus switching from brand name drug to generic one. However, either of 
this switching decision could significantly impact health and wellbeing of Medicare 
beneficiaries. The objective of the present study was to better understand the rela-
tive impacts of individual versus prescription plan level characteristics on both of 
these switching decisions. MethOds: Medicare beneficiaries participated in the 
2007 HRS prescription drug survey and 2009 HRS well-being survey and enrolled in 
Medicare part D (stand-alone), HMO, fee-for service or Advantage plans. The study 
sample includes 1298 individuals responded both years surveys. . Random inter-
cept multinomial logistic regression model was estimated. Results: Only 5% of 
sample members switched into different prescription plans in both 2007 and 2009, 
while about 24% individuals switched from brand name drugs to generic product to 
save prescription drug costs. An outcome variable of interest includes 4 categories: 
switched into different part D plan, switch from brand to generic drug, thought about 
switching but did not actually switch and didn’t do anything. The main covariates 
of interest include individual and plan level characteristics. Compared to “didn’t do 
anything” Individuals were more likely to switch to different prescription plan (13%) or 
switched into generic drug from brand name (25%) if they were using higher number 
of prescription medications (p< 0.04). Individuals having plans with good customer 
service was 54% less likely to switch into different part-D plan. Compared to “didn’t 
do anything” individuals were 123% more likely to stay on the same plan being not 
satisfied with the current plan if they experience “inertia” in the plan choice deci-
sion. cOnclusiOns: Unobserved plan level characteristics matter in part-D plan 
switching or drug switching decisions. Consumer inertia and plan’s customer service 
quality appear to be important factors influencing these switching decisions.
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IMPrOveMent effOrtS
Jeswani N, Gaur P, Ganesan N, Mitchell K
Avalere Health, Washington, DC, USA
Objectives: As healthcare becomes more patient-centered, patient-reported out-
comes (PROs) are assuming a growing role in different aspects of care. Avalere sought 
to define a conceptual framework on the criteria for defining, implementing, and 
translating PROs into valid, reliable measures of performance. MethOds: Conducted 
a structured literature review to identify influencers in the translation of PROs, issues 
that impact translation, and relationships between key variables. Results: Various 
